Q3 2016 EPS Estimates for Stericycle Inc. (SRCL) Increased by Analyst
Stericycle Inc. (NASDAQ:SRCL) – Research analysts at Wedbush upped their Q3 2016 earnings per share (EPS) estimates for Stericycle in a research report issued on Thursday. Wedbush analyst A. Kaschalk now forecasts that the brokerage will post earnings per share of $1.20 for the quarter, up from their previous forecast of $1.19. Wedbush currently has a “Neutral” rating and a $85.00 price target on the stock. Wedbush also issued estimates for Stericycle’s Q1 2017 earnings at $1.11 EPS, Q2 2017 earnings at $1.15 EPS, FY2017 earnings at $4.75 EPS, Q1 2018 earnings at $1.19 EPS and FY2018 earnings at $5.12 EPS.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.18. The company earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm’s quarterly revenue was up 24.6% on a year-over-year basis. During the same quarter last year, the company earned $1.14 earnings per share.
Several other research firms have also recently issued reports on SRCL. Zacks Investment Research cut Stericycle from a “buy” rating to a “hold” rating in a research report on Monday, July 25th. Imperial Capital cut Stericycle from an “in-line” rating to an “underperform” rating and lowered their price objective for the company from $100.00 to $93.50 in a research report on Friday, July 29th. Jefferies Group reaffirmed a “buy” rating and issued a $125.00 price objective (down from $140.00) on shares of Stericycle in a research report on Friday, July 29th. Wellington Shields cut Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Finally, Macquarie assumed coverage on Stericycle in a research report on Thursday, August 25th. They issued a “neutral” rating and a $96.00 price objective on the stock. Four analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $104.95.
Shares of Stericycle (NASDAQ:SRCL) opened at 80.26 on Monday. Stericycle has a 1-year low of $76.76 and a 1-year high of $151.57. The company has a market cap of $6.83 billion, a price-to-earnings ratio of 28.25 and a beta of 0.27. The company’s 50-day moving average price is $83.43 and its 200 day moving average price is $101.33.
Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Stericycle by 1.8% in the second quarter. Vanguard Group Inc. now owns 7,471,494 shares of the company’s stock valued at $777,932,000 after buying an additional 135,168 shares in the last quarter. State Street Corp increased its position in shares of Stericycle by 0.5% in the first quarter. State Street Corp now owns 3,593,337 shares of the company’s stock valued at $453,442,000 after buying an additional 19,317 shares in the last quarter. Baillie Gifford & Co. increased its position in shares of Stericycle by 77.2% in the second quarter. Baillie Gifford & Co. now owns 2,940,515 shares of the company’s stock valued at $306,166,000 after buying an additional 1,281,519 shares in the last quarter. Jana Partners LLC purchased a new position in shares of Stericycle during the first quarter valued at $305,997,000. Finally, BlackRock Institutional Trust Company N.A. increased its position in shares of Stericycle by 0.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,289,722 shares of the company’s stock valued at $288,940,000 after buying an additional 19,063 shares in the last quarter. 92.80% of the stock is owned by institutional investors.
In related news, EVP John P. Schetz sold 1,398 shares of the company’s stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Mark C. Miller sold 34,835 shares of the company’s stock in a transaction on Friday, July 8th. The stock was sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the completion of the transaction, the director now directly owns 244,284 shares of the company’s stock, valued at approximately $25,532,563.68. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by corporate insiders.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.